Cited by 52HIV, Drug Use, Sexual RiskHealth Policy Implementation ScienceSubstance Abuse Treatment and Outcomes

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

A scoping review of implementation considerations for harm reduction vending machines

Open access
Russell, Erin, Johnson, Jessica, Kosinski, Zach, Kaplan, Callie, Barnes, Nicole, Allen, Sean, Haroz, Emily·2023·Harm Reduction Journal

Published version of a preprint

Abstract

Background: Community-based harm reduction vending machines (HRVM) are not new to the field of public health; numerous countries have implemented them in response to the needs of people who use drugs over the last three decades. However, until recently, few existed in the United States. Given the rapidity with which communities are standing up harm reduction vending machines, there is a pressing need for a consolidated examination of implementation evidence. This scoping review summarizes existing literature using multiple implementation science frameworks. Methods: The scoping review was conducted in five stages including (1) Identify the research question; (2) Identify relevant studies; (3) Select the publications based on inclusion/exclusion criteria; (4) Review and extract data; and, (5) Summarize results. PubMed, Embase, and Web of Science were searched and authors screened publications in English from any year. Data were extracted by applying implementation constructs from RE-AIM and the Consolidated Framework for Implementation Research (CFIR). Both frameworks provided a useful lens through which to develop knowledge about the facilitators and barriers to HRVM implementation. The review is reported according to PRISMA guidelines. Results: After applying the full inclusion and exclusion criteria, including the intervention of interest (“vending machines”) and population of interest (“people who use drugs”), a total of 22 studies were included in the scoping review. None of the studies reported on race, making it difficult to retroactively apply a racial equity lens. Among those articles that examined effectiveness, the outcomes were mixed between clear effectiveness and inconclusive results. Evidence emerged, however, to address all CFIR constructs, and positive outcomes were observed from HRVM’s after-hour availability and increased program reach. Recommendations: HRVM implementation best practices include maximizing accessibility up to 24 h, 7 days a week, offering syringe disposal options, ensuring capability of data collection, and allowing for anonymity of use. Organizations that implement HRVM should establish strong feedback loops between them, their program participants, and the broader community upfront. Considerations for future research include rigorous study designs to evaluate effectiveness outcomes (e.g. reduced drug overdose deaths) and examination of HRVM reach among ethnic and racial communities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12954-023-00765-2

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 31

  1. Collins AB, Ndoye CD, Arene-Morley D, Marshall BDL. Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19. Int J Drug Policy. 2020;83:102872. https://doi.org/10.1016/j.drugpo.2020.102872. · DOI
  2. Friedman J, Beletsky L, Jordan A. Surging racial disparities in the U.S. overdose crisis. Am J Psychiatry. 2022;179:166–9. https://doi.org/10.1176/appi.ajp.2021.21040381. · DOI
  3. Rosales R, Janssen T, Yermash J, Yap KR, Ball EL, Hartzler B, et al. Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19. J Subst Abuse Treat. 2022;132:108648. https://doi.org/10.1016/j.jsat.2021.108648. · DOI
  4. Kariisa M, Davis NL, Kumar S, Seth P, Mattson CL, Chowdhury F, et al. Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics—25 states and the District of Columbia, 2019–2020. MMWR Morb Mortal Wkly Rep. 2022;71:940–7. https://doi.org/10.15585/mmwr.mm7129e2. · DOI
  5. McDonald D. The evaluation of a trial of syringe vending machines in Canberra, Australia. Int J Drug Policy. 2009;20:336–9. https://doi.org/10.1016/j.drugpo.2008.06.004. · DOI
  6. Obadia Y, Feroni I, Perrin V, Vlahov D, Moatti JP. Syringe vending machines for injection drug users: an experiment in Marseille, France. Am J Public Health. 1999;89:1852–4. https://doi.org/10.2105/ajph.89.12.1852. · DOI
  7. Strike C, Miskovic M. Scoping out the literature on mobile needle and syringe programs-review of service delivery and client characteristics, operation, utilization, referrals, and impact. Harm Reduct J. 2018;15:6. https://doi.org/10.1186/s12954-018-0212-3. · DOI
  8. Diseth TH. The syringe dispenser project in Larvik. Experiences after one year. Tidsskr Nor Laegeforen. 1989;109:3345–8.
  9. Shirley-Beavan S. The state of harm reduction in Western Europe 2018. Harm Reduction International; 2019.
  10. AP. PR group tests syringe vending machine for addicts. CBS News; 2009.
  11. Breitenbach S. Las Vegas offers needle exchange program through vending machines. The Washington Post; 2017.
  12. Kelly E. “Harm reduction” vending machine is stocked with free Narcan. Kentucky: Spectrum News 1; 2021.
  13. Paz IG. New York plans to install ‘Vending Machines’ with anti-overdose drugs. The New York Times; 2022.
  14. Islam M, Wodak A, Conigrave KM. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings. Int J Drug Policy. 2008;19:436–41. https://doi.org/10.1016/j.drugpo.2007.07.006. · DOI
  15. Brownson RC, Kumanyika SK, Kreuter MW, Haire-Joshu D. Implementation science should give higher priority to health equity. Implement Sci. 2021;16:28. https://doi.org/10.1186/s13012-021-01097-0. · DOI
  16. Glasgow RE, Harden SM, Gaglio B, Rabin B, Smith ML, Porter GC, et al. RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review. Front Public Health. 2019;7:64. https://doi.org/10.3389/fpubh.2019.00064. · DOI · Paper page
  17. Dodding J, Gaughwin M. The syringe in the machine. Aust J Public Health. 1995;19:406–9. https://doi.org/10.1111/j.1753-6405.1995.tb00395.x. · DOI
  18. Islam MM, Conigrave KM. Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review. Harm Reduct J. 2007;4:14. https://doi.org/10.1186/1477-7517-4-14. · DOI
  19. Otiashvili D, Kirtadze I, Vardanashvili I, Tabatadze M, Ober AJ. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia. Harm Reduct J. 2019;16:21. https://doi.org/10.1186/s12954-019-0292-8. · DOI
  20. Philbin MM, Mantsios A, Lozada R, Case P, Pollini RA, Alvelais J, et al. Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico. Int J Drug Policy. 2008;20:329–35. https://doi.org/10.1016/j.drugpo.2008.09.002. · DOI
  21. Day CA, White B, Haber PS. The impact of an automatic syringe dispensing machine in inner-city Sydney, Australia: no evidence of a “honey-pot” effect. Drug Alcohol Rev. 2016;35:637–43. https://doi.org/10.1111/dar.12397. · DOI
  22. Islam M, Stern T, Conigrave KM, Wodak A. Client satisfaction and risk behaviours of the users of syringe dispensing machines: a pilot study. Drug Alcohol Rev. 2008;27:13–9. https://doi.org/10.1080/09595230701711199. · DOI
  23. Stark K, Leicht A, Müller R. Characteristics of users of syringe vending machines in Berlin. Soz Praventivmed. 1994;39:209–16. https://doi.org/10.1007/BF01309220. · DOI
  24. Otiashvili D, Kirtadze I, Mgebrishvili T, Beselia A, Tabatadze M, Vardanashvili I, et al. Implementation and evaluation of a syringe vending machine trial in Tbilisi, Georgia. Int J Drug Policy. 2022;103:103649. https://doi.org/10.1016/j.drugpo.2022.103649. · DOI
  25. Moatti JP, Vlahov D, Feroni I, Perrin V, Obadia Y. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. Eur Addict Res. 2001;7:40–5. https://doi.org/10.1159/000050713. · DOI
  26. Allen ST, O’Rourke A, Johnson JA, Cheatom C, Zhang Y, Delise B, et al. Evaluating the impact of naloxone dispensation at public health vending machines in Clark County, Nevada. Ann Med. 2022;54:2692–700. https://doi.org/10.1080/07853890.2022.2121418. · DOI
  27. Duplessy C, Reynaud EG. Long-term survey of a syringe-dispensing machine needle exchange program: answering public concerns. Harm Reduct J. 2014;11:16. https://doi.org/10.1186/1477-7517-11-16. · DOI
  28. Otiashvili D, Kirtadze I, Mgebrishvili T, Beselia A, Tabatadze M, Otiashvili N, et al. Smart syringe vending machines: research capabilities and implications for research data collection. J Stud Alcohol Drugs. 2021;82:752–7. · DOI
  29. White B, Haber PS, Day CA. Community attitudes towards harm reduction services and a newly established needle and syringe automatic dispensing machine in an inner-city area of Sydney, Australia. Int J Drug Policy. 2016;27:121–6. https://doi.org/10.1016/j.drugpo.2015.05.010. · DOI
  30. Deimel D, Felix O, Bock C, Stöver H. Harm reduction 24/7: evaluation of the vending machine program for drug users in North Rhine-Westphalia-Germany. Heroin Addict Relat Clin Probl. 2020;22:29–38.
  31. Islam MM, Conigrave KM, Stern T. Staff perceptions of syringe dispensing machines in Australia: a pilot study. Subst Use Misuse. 2009;44:490–501. https://doi.org/10.1080/10826080802344757. · DOI

Metadata

Authors
Russell, E., Johnson, J., Kosinski, Z., Kaplan, C., Barnes, N., Allen, S., & Haroz, E.
Corresponding author
Russell, Erin
Venue
Harm Reduction Journal
Published
2023-03-16
Volume
20
Issue
1
Pages
33-33
ISSN
1477-7517 (ISSN-L)
OpenAlex
W4327685817
Cited by
52
References
3
Citations by year
2026: 19 · 2025: 20 · 2024: 11 · 2023: 2
FWCI
2.02
Type
journal article
Language
en
Open access
Locations
  • Harm Reduction Journal (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
drug users, implementation science, syringe access, syringe disposal, program reach, barriers and facilitators, racial equity, overdose prevention, RE-AIM framework, Consolidated Framework for Implementation Research
MeSH terms
Humans, United States, Substance-Related Disorders, Harm Reduction, Drug Users

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review